Welcome to our dedicated page for Bioceres Crop Solutions news (Ticker: BIOX), a resource for investors and traders seeking the latest updates and insights on Bioceres Crop Solutions stock.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) regularly issues news and updates that reflect its role in agricultural biotechnology, crop inputs and sustainable farming practices. Company announcements frequently describe new developments in its crop protection, seed and integrated products, and crop nutrition segments, as well as progress on its HB4 technology platform and biological solutions.
Investors and industry followers can use this news feed to monitor Bioceres’ financial performance, including quarterly and full-year results prepared under IFRS. Earnings releases typically cover revenues by segment, gross profit and margin trends, operating profit or loss, net income or loss and Adjusted EBITDA, along with commentary on working capital, cash flow and cost structure adjustments.
Bioceres’ news also highlights technology and regulatory milestones. Recent communications include the EPA registration of the Rinotec insecticide and nematicide platform in the United States, commercialization approvals in Brazil, and patent protection for HB4 wheat in the U.S. until 2042. The company has also reported a strategic collaboration with the Colorado Wheat Research Foundation to develop and commercialize HB4 wheat in the United States under an open licensing model.
Corporate governance and financing developments appear in the company’s updates as well, such as changes to the Board of Directors and senior management, amendments to note purchase agreements, and disclosures related to noteholder communications and litigation. By following this page, readers can track how Bioceres communicates its segment performance, capital structure actions and progress on its biotech and biological platforms across key agricultural markets.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced the import approval of its HB4 Wheat flour for consumption in Brazil, marking a significant milestone in biotechnology. The Brazilian National Biosafety Commission unanimously endorsed the biosafety of this genetically modified wheat, following rigorous safety evaluations. This approval paves the way for commercializing HB4 Wheat, critical for sustainable agriculture and a response to climate change. Bioceres has begun harvesting HB4 Wheat across 55,000 hectares and plans to share acreage projections in its upcoming earnings call.
Bioceres Crop Solutions (NASDAQ: BIOX) reported a 54% increase in total comparable revenues for the first quarter of fiscal year 2022, reaching $64.8 million. The growth is attributed to effective commercial strategies in the Crop Nutrition and Protection segments and favorable market conditions in Latin America. The company’s LTM Adjusted EBITDA hit $50.2 million, incorporating $3.4 million in pre-operational expenses from the HB4 program. Notably, the Crop Nutrition segment accounted for 44% of revenue growth. Regulatory approvals from Brazil and China continue to progress without issues.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) will host a conference call on November 10, 2021, at 8:30 a.m. Eastern Time, to discuss its fiscal first quarter results ending September 30, 2021. The call will feature Chairman & CEO Federico Trucco, CFO Enrique Lopez Lecube, and Head of Investor Relations Rodrigo Krause dos Santos Rocha, followed by a Q&A session. Participants can join via a toll-free number or webcast, with replay available until November 15, 2021. Bioceres focuses on crop productivity solutions aimed at achieving carbon neutrality in agriculture.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) has been invited to present at Lake Street’s 5th Annual Best Ideas Growth (BIG5) Conference, taking place virtually on September 14-15, 2021. CEO Federico Trucco and CFO Enrique Lopez Lecube will hold 30-minute video meetings to discuss Q4 and FY results ending June 30, 2021, the HB4 program, and future milestones. The BIG Conference connects executives from over 100 public growth companies with institutional investors in an interactive format, emphasizing the importance of innovative agricultural solutions.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) reported a robust fiscal fourth quarter for 2021, with comparable revenues increasing by 39% YoY to $72.4 million and adjusted EBITDA rising 13% to $16.6 million. For the full year, revenues were up 13% to $197.4 million, driven by micro-beaded fertilizers and a restructured Crop Protection division. The company has expanded its HB4 collaboration with GDM into North America, targeting 10 million hectares prone to water deficits. Additionally, total financing of $71.5 million was secured during the fiscal year, enhancing liquidity.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced that its subsidiary Rizobacter Argentina S.A. has successfully completed a $16.1 million public offering of Series VI corporate bonds in Argentina. The offering consists of two tranches: Class A, totaling $12.7 million with a maturity in March 2023 at an interest rate of 3.75%, and Class B, amounting to $3.4 million with a maturity in September 2024 at 5.25%. Proceeds will support working capital, extend debt maturities, and lower financing costs.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) will hold a conference call on September 9, 2021, at 8:30 a.m. ET to discuss Q4 and fiscal year results ending June 30, 2021. Key executives will lead the discussion, followed by a Q&A session. Investors can access the call via toll-free and international numbers, and there will be a webcast available for viewing. A replay will be accessible until September 14, 2021. Bioceres focuses on sustainable agricultural solutions and advanced crop productivity technologies.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced its participation in the Jefferies 2021 Industrials Conference on August 4, 2021. CEO Federico Trucco will hold one-on-one video meetings and deliver a 25-minute presentation at 1:00 pm ET. This conference aims to address agricultural advancements towards carbon neutrality. The company's innovative solutions and biotechnology platforms are designed to incentivize eco-friendly farming practices. More details and the webcast link are available on the conference website.
PlantArcBio has signed a collaboration agreement with Bioceres Crop Solutions (NASDAQ: BIOX) to develop drought-resistant and high-biomass Alfalfa. Bioceres gains exclusive licensing rights to PlantArcBio's patented genes, discovered in Dead Sea soil, which enhance drought resistance and biomass in various crops. This partnership is aimed at leveraging Bioceres' expertise in crop development to create superior Alfalfa varieties for commercial use. The global market for Alfalfa hay is projected to grow to US$20.6 billion by 2025, indicating significant demand growth in the agriculture sector.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced its participation in the 7th Annual Roth Virtual London Conference, taking place from June 21-23, 2021. The company aims to promote its carbon-neutral agricultural solutions during this event. CFO Enrique López Lecube will conduct 40-minute video meetings on June 22 and 23, from 7:00 a.m. to 2:25 p.m. Eastern time. Participants can schedule individual meetings through the conference website or by contacting BIOX@mzgroup.us.
Bioceres specializes in pioneering crop productivity technologies and aims to incentivize sustainable farming practices.
FAQ
What is the current stock price of Bioceres Crop Solutions (BIOX)?
What is the market cap of Bioceres Crop Solutions (BIOX)?
